Reading your bloodwork

You weren’t told you’re healthy. You were told you’re average.

Your doctor didn’t tell you that you’re fine. Your doctor told you that you’re not sick enough to code. Those are different sentences, and only one of them gets reimbursed.

The short version

  • A reference range is the middle 95% of a population — not a standard of health.
  • That population has been getting metabolically sicker for thirty years, so “normal” drifts down with it.
  • Most of what would actually explain how you feel was never ordered.
Skip to the marker list

“Normal” is a percentile, not a verdict

A reference range means your result landed inside the middle 95% of whatever population the laboratory used to build it. Not that you’re well. Not that you’re where you should be. Just that you’re near the middle of the pack.

The obvious question, which almost nobody is invited to ask: near the middle of which pack?

Reference intervals are built by taking results from a reference population and keeping the central 95% — the 2.5th percentile to the 97.5th. That’s the standard method, and it’s applied honestly. But notice what it doesn’t involve. Nobody followed those people for twenty years to see who stayed healthy. No outcomes were measured. The range describes where most people’s numbers land, and stops there.

Two consequences follow, and neither is usually explained. Five percent of completely healthy people fall outside the range by arithmetic — run twenty tests on a well person and one comes back flagged, on average. And the range is only ever as healthy as the population behind it.

The mirror moves

Reference populations are assembled from whoever is available. People who showed up at the lab. Blood donors. Participants in national health surveys. These groups are screened, at best, for the absence of a diagnosed disease — not for health.

The American adult population is not metabolically well. By CDC estimates, a large majority of adults carry excess weight, and a substantial share meet criteria for prediabetes — most of them undiagnosed, and therefore fully eligible for a reference population.

As the population’s metabolic health declines, the statistical middle declines with it.

Normal is not a fixed biological standard. It is a running average of a country, and it has been drifting for thirty years.

Testosterone: watch the floor move

For years, laboratories published lower limits for total testosterone that varied widely — many near 250 ng/dL or below, drawn from mixed-age, mixed-health male populations.

In 2017, Travison and colleagues built harmonized reference ranges from a deliberately selected group: non-obese, non-diabetic, healthy men aged 19 to 39, across four large cohorts. The result was 264 to 916 ng/dL.

Travison TG, et al. J Clin Endocrinol Metab. 2017;102(4):1161–1173.

Take out the men with obesity and diabetes, and the distribution shifts. That’s the whole argument in one paper. A man sitting at the bottom of an older range was being measured against a group that included a great many men who were not well. He was told he was normal. He was told the truth — it just wasn’t the information he came for.

TSH: the range contains the disease

The standard range for thyroid-stimulating hormone runs roughly 0.45 to 4.5 mIU/L. Analysis of NHANES III data examined what happens when you remove people with thyroid antibodies, known thyroid disease, goiter, or family history from the reference population. In that disease-free group, the distribution is substantially narrower, with the large majority well below the standard ceiling.

Hollowell JG, et al. J Clin Endocrinol Metab. 2002;87(2):489–499.

Read plainly: part of what defines the top of the “normal” thyroid range is people with early thyroid disease. They were in the population. They hadn’t been diagnosed, so they weren’t excluded. And their numbers helped set the ceiling you were measured against.

The test that was never run

Here’s the part that costs people the most years, and it has nothing to do with reference ranges at all. You cannot be out of range on a test nobody ordered.

A standard annual panel is a CBC, a metabolic panel, a lipid panel, and if you’re lucky, a TSH. It does not include fasting insulin, free testosterone, SHBG, ApoB, Lp(a), hs-CRP, ferritin, or a full thyroid panel. Every one of those can be badly wrong while your standard panel comes back spotless.

Fasting insulin is the one that should make you angry. Insulin resistance develops years — often a decade — before glucose becomes abnormal. The pancreas compensates by producing more insulin, and it succeeds for a long time. Fasting glucose and HbA1c stay normal through that entire window, because they measure the outcome the compensation is busy preventing. Measure insulin and you see the compensation itself, while it’s still reversible.

The test costs less than lunch. It has a billing code. What it doesn’t have is a diagnosis waiting at the end of it — and in a system organized around diagnosis and reimbursement, that’s what decides whether a test gets ordered.

There is no code for tired at 42 with a testosterone of 310 and a fasting insulin of 18. There’s a code for hypogonadism, and one for type 2 diabetes, and you don’t have either yet. So you’re told you’re normal. Within the system’s own logic, you are.

Fifteen minutes is a billing interval

The typical primary care appointment runs about fifteen minutes. That number wasn’t arrived at clinically. Nobody studied how long it takes to understand a person’s metabolic health and concluded the answer was a quarter of an hour. It’s an economic artifact — the interval at which a practice covers its overhead under current reimbursement.

In fifteen minutes a physician has to review your history, address what you came in for, document to a standard that satisfies a payer, and code the visit. What doesn’t fit is a conversation about why you feel worse at 44 than you did at 38 when every number on the page is inside its brackets.

This is not a failure of the person in front of you. Most primary care physicians are excellent, working inside constraints they didn’t design and can’t fix from the exam room. The system is doing exactly what it was built to do: find disease, efficiently, at scale. It’s very good at that. It was never built to answer the question you actually walked in with.

The panel

What we actually measure

A marker that was never drawn can’t tell you anything. This is the shape of a panel built to answer how you’re functioning — not only whether you’re sick. Gold notes are the ones people most often get wrong.

CoreEveryone
Metabolic
Fasting insulinRises years before glucose does. The most under-ordered test in American medicine. Must be fasted.
Fasting glucoseWhere the problem finally shows up, long after it started.
HbA1cRoughly three months of average glucose. Skewed by anemia and red-cell turnover.
HOMA-IRCalculated from insulin and glucose together. Free, and more informative than either alone.
Cardiovascular
ApoBCounts atherogenic particles. When it disagrees with LDL-C, it’s the better predictor.
Lp(a)Largely genetic and largely fixed. Measure once in your life — most people never do.
Full lipid panelTotal, LDL-C, HDL, triglycerides. The triglyceride-to-HDL ratio is the part worth reading.
hs-CRPVascular inflammation. The high-sensitivity assay, not standard CRP.
HomocysteineRises with B12, folate and B6 insufficiency.
Thyroid
TSHA pituitary signal, not a thyroid measurement. Alone, it isn’t a thyroid panel.
Free T4 · Free T3The hormones themselves. Free T3 is what tissue actually uses.
TPO & Tg antibodiesAutoimmune thyroid disease shows here years before TSH moves.
Iron, nutrients, organ function
FerritinIron stores. Pair with hs-CRP — it’s an acute-phase reactant, so inflammation falsely raises it.
Vitamin D (25-OH)Insufficiency is common, cheap to find, cheap to fix.
B12 & folateFatigue and cognitive complaints trace here more often than people expect.
RBC magnesiumSerum magnesium is tightly buffered and tells you very little.
CMP · CBCLiver, kidney, electrolytes, blood counts. The baseline everything else is read against.
GGTAn early liver signal, and a reasonable proxy for alcohol load.
Uric acidTracks with metabolic dysfunction well before it ever causes gout.
AdditionalMen
Total testosteroneDraw before 10am. It’s diurnal — an afternoon draw can read 20–25% lower.
Free testosteroneThe active fraction. This is the number that tracks symptoms.
SHBGExplains a normal total sitting on top of a low free.
EstradiolSensitive (LC-MS) assay only. Standard immunoassay is unreliable at male concentrations.
LH & FSHSeparates a testicular problem from a pituitary one. Changes what you’d do next.
ProlactinAn elevated value can be the entire explanation, and it’s rarely checked.
DHEA-SAdrenal androgen output.
PSABaseline before any testosterone therapy, then monitored on it. Non-negotiable.
HematocritTestosterone raises it. Baseline first, then tracked.
IGF-1The growth hormone axis, read indirectly.
AdditionalWomen
EstradiolInterpreted against cycle day, or against menopausal status.
ProgesteroneTiming is everything. Luteal phase, around day 21, if still cycling. Otherwise it means nothing.
FSH & LHDay 3 if cycling. FSH is the marker of the menopausal transition.
Total & free testosteroneWomen produce it too, and low testosterone in women is real and under-recognised.
SHBGOral estrogen and combined contraception raise it substantially — which drops free testosterone.
DHEA-SAdrenal androgen output.
ProlactinAffects cycles, libido and mood. Cheap to rule out.
Thyroid antibodiesAutoimmune thyroid disease is several times more common in women.
FerritinThe highest-yield test on this list. Menstruating women are the top risk group, frequently with normal hemoglobin.
AMHOvarian reserve, where fertility or timing is part of the question.

Now the part nobody in this industry writes

Everything above gets used to sell things, constantly, by people who should know better. So here’s the other side, and we mean it.

“Optimal ranges” are frequently invented. A great many of the optimal ranges circulating in wellness marketing have no outcome data behind them at all. Someone picked a number that sounded better than the reference range and put it in a slide deck. That isn’t more rigorous than the lab’s range — it’s dramatically less, because at least the lab is transparent about what it measured. If a clinic shows you an optimal range, ask where it came from. If the answer isn’t a study, it’s a marketing decision. That includes ours.

Reference ranges are excellent at their actual job. They exist to flag likely disease across a population, quickly and cheaply, and they do it well. None of this means ignoring them. A value outside the range still demands attention, urgently.

Treating a number instead of a person is a real failure mode, and it’s rampant in our corner of medicine. A lab value that doesn’t match how someone feels is a reason to look harder, not a reason to write a prescription.

A reference range answers: is this person likely to have a disease?

It does not answer: is this person functioning as well as they could?

Both are legitimate questions. They need different tests, a different comparison, and more than fifteen minutes.

What we do with it

We read your numbers against your own history where you have one — bring old labs, because the trajectory is often more informative than today’s value. We interpret results next to your symptoms instead of instead of them. And we’ll tell you plainly when your labs genuinely are unremarkable and the answer is somewhere else.

Sleep apnea, iron deficiency, depression, medication effects and chronic under-sleeping produce the exact symptom picture most people arrive with, and not one of them is fixed by a hormone prescription. Selling you one anyway would be the same failure in a nicer building.

Find out what your numbers actually say.

Physician-led hormone and peptide care, 100% virtual. Start with a 30-minute consult.

Book a consult

References

  1. Travison TG, Vesper HW, Orwoll E, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. J Clin Endocrinol Metab. 2017;102(4):1161–1173.
  2. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): NHANES III. J Clin Endocrinol Metab. 2002;87(2):489–499.
  3. Clinical and Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory (EP28-A3c).
  4. Centers for Disease Control and Prevention. National Diabetes Statistics Report; NHANES obesity prevalence data.

Educational purposes only. This page is not medical advice and does not create a physician–patient relationship. Which markers are appropriate depends on your history, symptoms and medications, and should be decided with a licensed clinician. Elevate Chicago is a physician-led telehealth practice. 847-716-2273 · frank@elevate-chicago.com · @elevatewellnesschicago